-The purpose of the Rheumatology Training Program at the NYU School of Medicine is to prepare individuals for research and training in the broad area of rheumatology. As in prior iterations of this grant, the major effort will be directed to the training of MD's, or MD/PhD's in a rheumatology-related scientific discipline. Most of our trainees will also be trained in clinical rheumatology;it is expected that many of them will eventually assume responsible positions in rheumatology divisions in medical schools. Because of the nature of our staff, it is anticipated that we will also attract a number of PhDs for training in our laboratories. Each MD or MD/PhD will be expected to become proficient in all areas of clinical rheumatology, and to develop a general but thorough knowledge of 1) immunology, cell biology, molecular biology and genetics, and 2) epidemiology and biostatistics, as these disciplines pertain to the pathogenesis of rheumatic disease. Each trainee will then be expected to choose from two possible training tracks (basic science and clinical research), each with an option to pursue translationally-based projects. Trainees in each track will receive additional, in-depth training in their areas of interest, including the possibility of an advanced degree (MSCI, MPH). Trainees in each track will, in addition, pursue a rigorous program of scientific research in an appropriate area of rheumatology, under the direction of their primary research mentor. Productivity will be emphasized, and it is expected that each trainee's research will provide a basis for potential future work. In keeping with the past performance of our trainees, we expect that many will continue their work in basic and/or clinical rheumatology research, and that many will go on to become future academic leaders in rheumatology. Relevance-According to a recent CDC survey, the number of patients in the US suffering from rheumatic diseases numbers more than 60 million. By training future leaders of academic rheumatology, our training program is positioned to have a significant effect on the management of such patients in the future. Our research tracks will include training for future careers in bench research, clinical studies and outcomes;trainees successfully pursuing any one of these tracks will be well-positioned to generate new knowledge about, and have an impact on, the future treatment of rheumatic diseases in the U.S. PERFORMANCE SITE(S)

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1-EHB-J (O1))
Program Officer
Mancini, Marie
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Howard, Rennie G; Samuels, Jonathan; Gyftopoulos, Soterios et al. (2015) Presence of gout is associated with increased prevalence and severity of knee osteoarthritis among older men: results of a pilot study. J Clin Rheumatol 21:63-71
Attur, Mukundan; Ben-Artzi, Ami; Yang, Qing et al. (2012) Perturbation of nuclear lamin A causes cell death in chondrocytes. Arthritis Rheum 64:1940-9
Crittenden, Daria B; Lehmann, R Aaron; Schneck, Laura et al. (2012) Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. J Rheumatol 39:1458-64
Howard, Rennie G; Pillinger, Michael H; Gyftopoulos, Soterios et al. (2011) Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers. Arthritis Care Res (Hoboken) 63:1456-62
Keenan, Robert T; O'Brien, William R; Lee, Kristen H et al. (2011) Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 124:155-63
Attur, Mukundan G; Palmer, Glyn D; Al-Mussawir, Hayf E et al. (2009) F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation. FASEB J 23:79-89
Attur, Mukundan; Al-Mussawir, Hayf E; Patel, Jyoti et al. (2008) Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 181:5082-8
Park, Jean Y; Pillinger, Michael H; Abramson, Steven B (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 119:229-40
Pillinger, Michael H; Rosenthal, Pamela B; Tolani, Sonia N et al. (2003) Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J Immunol 171:6080-9
Capodici, C; Hanft, S; Feoktistov, M et al. (1998) Phosphatidylinositol 3-kinase mediates chemoattractant-stimulated, CD11b/CD18-dependent cell-cell adhesion of human neutrophils: evidence for an ERK-independent pathway. J Immunol 160:1901-9

Showing the most recent 10 out of 15 publications